[HTML][HTML] Immunotherapy summary for cytokine storm in COVID-19
Y Li, W Zhao, J Liu, Z Chen, Q Lv… - Frontiers in Pharmacology, 2021 - frontiersin.org
COVID-19 pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has ravaged the world, resulting in an alarming number of infections and deaths …
CoV-2) has ravaged the world, resulting in an alarming number of infections and deaths …
COVID-19: Between past and present
Since the WHO declared coronavirus disease 2019 (COVID-19) as a pandemic, huge efforts
were made to understand the disease, its pathogenesis, and treatment. COVID-19 is caused …
were made to understand the disease, its pathogenesis, and treatment. COVID-19 is caused …
[HTML][HTML] Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features
The novel coronavirus pandemic has emerged as one of the significant medical-health
challenges of the current century. The World Health Organization has named this new virus …
challenges of the current century. The World Health Organization has named this new virus …
[HTML][HTML] The development of COVID-19 treatment
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest …
a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest …
[HTML][HTML] Immune-based therapeutic approaches in COVID-19
Abstract Coronavirus disease 2019 (COVID-19) is a viral disease caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), a member of the Coronaviridae family …
respiratory syndrome coronavirus-2 (SARS-CoV-2), a member of the Coronaviridae family …
[HTML][HTML] Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19
Coronaviruses are non-segmented and single stranded positive-sense RNA (+ ssRNA)
viruses. To date, 06 human coronaviruses (HCoVs) are reported; α-CoVs (HCoVs-NL63 and …
viruses. To date, 06 human coronaviruses (HCoVs) are reported; α-CoVs (HCoVs-NL63 and …
[HTML][HTML] Recent insight into SARS-CoV2 immunopathology and rationale for potential treatment and preventive strategies in COVID-19
As the outbreak of the new coronavirus (SARS-CoV-2) infection is spreading globally, great
effort is being made to understand the disease pathogenesis and host factors that …
effort is being made to understand the disease pathogenesis and host factors that …
[HTML][HTML] Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs …
AA Rabaan, SH Al-Ahmed, J Muhammad, A Khan… - Vaccines, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
P Goodarzi, F Mahdavi, R Mirzaei, H Hasanvand… - International …, 2020 - Elsevier
The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …
[PDF][PDF] Adjunct immunotherapies for the management of severely ill COVID-19 patients
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …